|
Volumn 28, Issue 3, 1996, Pages 1548-1550
|
Clinical implication of hormone treatment in postmenopausal kidney transplants
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CALCITONIN;
CYCLOSPORIN;
ESTROGEN;
FOLLITROPIN;
LUTEINIZING HORMONE;
PARATHYROID HORMONE;
PREDNISOLONE;
PROGESTERONE;
ADULT;
AGED;
BONE MINERAL;
CLINICAL ARTICLE;
CONFERENCE PAPER;
DENSITOMETRY;
DRUG EFFICACY;
FEMALE;
GRAFT REJECTION;
HORMONAL THERAPY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
MALE;
OSTEOPOROSIS;
POSTMENOPAUSE;
PRIORITY JOURNAL;
TREATMENT INDICATION;
ADULT;
AGED;
BONE DENSITY;
CALCITONIN;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS;
FEMALE;
FOLLICLE STIMULATING HORMONE;
HORMONES;
HUMANS;
KIDNEY TRANSPLANTATION;
LUTEINIZING HORMONE;
MALE;
MIDDLE AGED;
OSTEOPOROSIS;
PARATHYROID HORMONE;
POSTMENOPAUSE;
PREMENOPAUSE;
PROGESTERONE;
|
EID: 0029884224
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (14)
|
References (0)
|